Cargando…
Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common form of dementia in the world. Microglia are the innate immune cells of CNS; their proliferation, activation, and survival in pathologic and healthy brain have previously been shown to be highly depe...
Autores principales: | Pons, Vincent, Lévesque, Pascal, Plante, Marie-Michèle, Rivest, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783991/ https://www.ncbi.nlm.nih.gov/pubmed/33402196 http://dx.doi.org/10.1186/s13195-020-00747-7 |
Ejemplares similares
-
Muramyl Dipeptide Administration Delays Alzheimer’s Disease Physiopathology via NOD2 Receptors
por: Piec, Pierre-Alexandre, et al.
Publicado: (2022) -
New Therapeutic Avenues of mCSF for Brain Diseases and Injuries
por: Pons, Vincent, et al.
Publicado: (2018) -
Beneficial Roles of Microglia and Growth Factors in MS, a Brief Review
por: Pons, Vincent, et al.
Publicado: (2020) -
Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
por: Anwar, Shehata, et al.
Publicado: (2020) -
The dynamics of monocytes and microglia in Alzheimer’s disease
por: Thériault, Peter, et al.
Publicado: (2015)